Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Nucleotide Excision Repair and Vitamin D--Relevance for Skin Cancer Therapy.

Pawlowska E, Wysokinski D, Blasiak J.

Int J Mol Sci. 2016 Apr 6;17(4):372. doi: 10.3390/ijms17040372. Review.

2.

Association Between Prediagnostic Serum 25-Hydroxyvitamin D Concentration and Glioma.

Zigmont V, Garrett A, Peng J, Seweryn M, Rempala GA, Harris R, Holloman C, Gundersen TE, Ahlbom A, Feychting M, Johannesen TB, Grimsrud TK, Schwartzbaum J.

Nutr Cancer. 2015;67(7):1120-30. doi: 10.1080/01635581.2015.1073757.

3.

Vitamin D Deficiency and Hashimoto's Thyroiditis in Children and Adolescents: a Critical Vitamin D Level for This Association?

Evliyaoğlu O, Acar M, Özcabı B, Erginöz E, Bucak F, Ercan O, Kucur M.

J Clin Res Pediatr Endocrinol. 2015 Jun;7(2):128-33. doi: 10.4274/jcrpe.2011.

4.

Mechanistic Effects of Calcitriol in Cancer Biology.

Díaz L, Díaz-Muñoz M, García-Gaytán AC, Méndez I.

Nutrients. 2015 Jun 19;7(6):5020-50. doi: 10.3390/nu7065020. Review.

5.

Vitamin D Receptor Polymorphisms Are Associated with Reduced Esophageal Vitamin D Receptor Expression and Reduced Esophageal Adenocarcinoma Risk.

Janmaat VT, Van De Winkel A, Peppelenbosch MP, Spaander MC, Uitterlinden AG, Pourfarzad F, Tilanus HW, Rygiel AM, Moons LM, Arp PP, Krishnadath KK, Kuipers EJ, Van Der Laan LJ.

Mol Med. 2015 Apr 21;21:346-54. doi: 10.2119/molmed.2012.00336.

6.

Vitamin D in asthma and future perspectives.

Huang H, Porpodis K, Zarogoulidis P, Domvri K, Giouleka P, Papaiwannou A, Primikyri S, Mylonaki E, Spyratos D, Hohenforst-Schmidt W, Kioumis I, Zarogoulidis K.

Drug Des Devel Ther. 2013 Sep 23;7:1003-13. doi: 10.2147/DDDT.S50599. Review.

7.

Protein biomarkers distinguish between high- and low-risk pediatric acute lymphoblastic leukemia in a tissue specific manner.

Braoudaki M, Lambrou GI, Vougas K, Karamolegou K, Tsangaris GT, Tzortzatou-Stathopoulou F.

J Hematol Oncol. 2013 Jul 12;6:52. doi: 10.1186/1756-8722-6-52.

8.

Down-regulation of vitamin D receptor in mammospheres: implications for vitamin D resistance in breast cancer and potential for combination therapy.

Pervin S, Hewison M, Braga M, Tran L, Chun R, Karam A, Chaudhuri G, Norris K, Singh R.

PLoS One. 2013;8(1):e53287. doi: 10.1371/journal.pone.0053287. Erratum in: PLoS One. 2013;8(10). doi:10.1371/annotation/5326d117-3f31-4e43-a5c4-9e1fb41719e9.

9.

The nonskeletal effects of vitamin D: an Endocrine Society scientific statement.

Rosen CJ, Adams JS, Bikle DD, Black DM, Demay MB, Manson JE, Murad MH, Kovacs CS.

Endocr Rev. 2012 Jun;33(3):456-92. doi: 10.1210/er.2012-1000. Review.

10.

Dietary supplements and cancer prevention: balancing potential benefits against proven harms.

Martínez ME, Jacobs ET, Baron JA, Marshall JR, Byers T.

J Natl Cancer Inst. 2012 May 16;104(10):732-9. doi: 10.1093/jnci/djs195.

11.

Dietary calcium and risk for prostate cancer: a case-control study among US veterans.

Williams CD, Whitley BM, Hoyo C, Grant DJ, Schwartz GG, Presti JC Jr, Iraggi JD, Newman KA, Gerber L, Taylor LA, McKeever MG, Freedland SJ.

Prev Chronic Dis. 2012;9:E39.

12.

Systems biology-based analysis implicates a novel role for vitamin D metabolism in the pathogenesis of age-related macular degeneration.

Morrison MA, Silveira AC, Huynh N, Jun G, Smith SE, Zacharaki F, Sato H, Loomis S, Andreoli MT, Adams SM, Radeke MJ, Jelcick AS, Yuan Y, Tsiloulis AN, Chatzoulis DZ, Silvestri G, Kotoula MG, Tsironi EE, Hollis BW, Chen R, Haider NB, Miller JW, Farrer LA, Hageman GS, Kim IK, Schaumberg DA, DeAngelis MM.

Hum Genomics. 2011 Oct;5(6):538-68.

13.

Vitamin d, sunlight and prostate cancer risk.

Donkena KV, Young CY.

Adv Prev Med. 2011;2011:281863. doi: 10.4061/2011/281863.

14.

The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease.

Manson JE, Bassuk SS, Lee IM, Cook NR, Albert MA, Gordon D, Zaharris E, Macfadyen JG, Danielson E, Lin J, Zhang SM, Buring JE.

Contemp Clin Trials. 2012 Jan;33(1):159-71. doi: 10.1016/j.cct.2011.09.009.

15.
16.

Diabetes and thyroid cancer risk in the National Institutes of Health-AARP Diet and Health Study.

Aschebrook-Kilfoy B, Sabra MM, Brenner A, Moore SC, Ron E, Schatzkin A, Hollenbeck A, Ward MH.

Thyroid. 2011 Sep;21(9):957-63. doi: 10.1089/thy.2010.0396.

17.

Nutrigenomics, vitamin D and cancer prevention.

Davis CD, Milner JA.

J Nutrigenet Nutrigenomics. 2011;4(1):1-11. doi: 10.1159/000324175. Review.

18.

Total cholesterol and cancer risk in a large prospective study in Korea.

Kitahara CM, Berrington de González A, Freedman ND, Huxley R, Mok Y, Jee SH, Samet JM.

J Clin Oncol. 2011 Apr 20;29(12):1592-8. doi: 10.1200/JCO.2010.31.5200.

19.

Vitamin D supplementation in the pediatric rheumatology clinic.

von Scheven E, Burnham JM.

Curr Rheumatol Rep. 2011 Apr;13(2):110-6. doi: 10.1007/s11926-010-0161-7.

20.

The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know.

Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, Gallagher JC, Gallo RL, Jones G, Kovacs CS, Mayne ST, Rosen CJ, Shapses SA.

J Clin Endocrinol Metab. 2011 Jan;96(1):53-8. doi: 10.1210/jc.2010-2704.

Supplemental Content

Support Center